These 3 Biotech Stocks Have MAJOR Catalysts Coming (Get in Before the Move)

Podcast: MarketBeat | Stock Market News & Analysis · MarketBeat

Opublikowano: 2026-09-20

Get the FREE Report on 7 Stocks to Buy and Hold Forever: https://www.marketbeat.com/y/yt991/ Three biotech stocks. Three major FDA catalysts. And the results could send these stocks soaring or send them tumbling. MarketBeat analyst Chris Markoch joins Bridget to break down Kodiak Sciences, Capricor Therapeutics, and Invivyd, three small-cap biotechs all approaching binary, high-stakes FDA events. Chris walks through why FDA catalysts move biotech stocks more than almost any other sector, what separates a late-stage phase three trial from an early one, and how to think about institutional ownership and short interest...